FDA Adverse Event Electronic Reporting Delayed To Complete Portal Roll-Out
This article was originally published in The Pink Sheet Daily
Executive Summary
Because some submitters will not have enough time to register for new electronic submission system, FDA will continue accepting paper post-marketing safety reports a little longer.
You may also be interested in...
FDA Adverse Event Reporting Reg Offers Few Exceptions
Companies must submit post-market safety reports electronically beginning in June 2015; waivers will be allowed, but they would only be temporary.
Adverse Event Rule Would Require e-Conversion Of 20 Percent Of Submissions
FDA's proposed rule to require electronic submission of adverse event information would mandate a switch that industry already seems to be making rapidly
Patient-Focused Drug Development, Complex Trial Design May Not Get More Funding In PDUFA VII
US FDA proposed increasing staffing and resources for both programs during the next user fee program cycle, but industry representatives did not believe it necessary.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: